These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36075766)

  • 1. [What should a cardiologist know about the follow-up and management of a woman with breast cancer ?].
    Jagu A
    Ann Cardiol Angeiol (Paris); 2022 Nov; 71(5):304-308. PubMed ID: 36075766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of echocardiography in the detection and the monitoring of left ventricular systolic dysfunction in patients undergoing cancer therapy].
    Charbonnel C
    Ann Cardiol Angeiol (Paris); 2020 Nov; 69(5):255-261. PubMed ID: 32962803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of new and emerging cancer drugs: what the cardiologist needs to know.
    Fabiani I; Chianca M; Aimo A; Emdin M; Dent S; Fedele A; Cipolla CM; Cardinale DM
    Eur Heart J; 2024 Jun; 45(22):1971-1987. PubMed ID: 38591670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential impact of cardiac dose-volume on acute cardiac toxicity following concurrent trastuzumab and radiotherapy.
    Cao L; Hu WG; Kirova YM; Yang ZZ; Cai G; Yu XL; Ma JL; Guo XM; Shao ZM; Chen JY
    Cancer Radiother; 2014 Mar; 18(2):119-24. PubMed ID: 24642505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The European Association of Cardiovascular Imaging/Heart Failure Association Cardiac Oncology Toxicity Registry: long-term benefits for breast cancer treatment.
    Jerusalem G; Moonen M; Freres P; Lancellotti P
    Future Oncol; 2015; 11(20):2791-4. PubMed ID: 26344798
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation and management of chemotherapy-induced cardiotoxicity in breast cancer: a Delphi study.
    Gavila J; Seguí MÁ; Calvo L; López T; Alonso JJ; Farto M; Sánchez-de la Rosa R
    Clin Transl Oncol; 2017 Jan; 19(1):91-104. PubMed ID: 27101413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiotoxicity and Cardiac Monitoring Among Chemotherapy-Treated Breast Cancer Patients.
    Henry ML; Niu J; Zhang N; Giordano SH; Chavez-MacGregor M
    JACC Cardiovasc Imaging; 2018 Aug; 11(8):1084-1093. PubMed ID: 30092967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardio-oncology: management of cardiovascular toxicity.
    Markman TM; Markman M
    F1000Res; 2019; 8():. PubMed ID: 30755794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiotoxicity of systemic agents used in breast cancer.
    Ades F; Zardavas D; Pinto AC; Criscitiello C; Aftimos P; de Azambuja E
    Breast; 2014 Aug; 23(4):317-28. PubMed ID: 24794210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiotoxicity of Contemporary Breast Cancer Treatments.
    Lee Chuy K; Yu AF
    Curr Treat Options Oncol; 2019 May; 20(6):51. PubMed ID: 31073788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of cardiac toxicity of systemic treatments in Moroccan patients followed for localized breast cancer: Prospective observational study of 549 cases.
    Haffadi M; Tawfiq N; Dakir M; Boughafour M; Bouchbika Z; Benchakroun N; Jouhadi H; Sahraoui S; Benider A; Krikez I; Benmallek R; Habbal R
    Gulf J Oncolog; 2021 Jan; 1(35):59-65. PubMed ID: 33716214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic factors in the pathogenesis of cardio-oncology.
    Qi Y; Wei Y; Li L; Ge H; Wang Y; Zeng C; Ma F
    J Transl Med; 2024 Aug; 22(1):739. PubMed ID: 39103883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galician consensus on management of cardiotoxicity in breast cancer: risk factors, prevention, and early intervention.
    Cueva JF; Antolín S; Calvo L; Fernández I; Ramos M; de Paz L; Mata JG; López R; Constenla M; Pérez E; González A; Pellón ML; Varela S; López T
    Clin Transl Oncol; 2017 Sep; 19(9):1067-1078. PubMed ID: 28342058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits of antihypertensive medications for anthracycline- and trastuzumab-induced cardiotoxicity in patients with breast cancer: Insights from recent clinical trials.
    Rygiel K
    Indian J Pharmacol; 2016; 48(5):490-497. PubMed ID: 27721532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting and preventing cardiotoxicity in the era of breast cancer targeted therapies. Novel molecular tools for clinical issues.
    Zambelli A; Della Porta MG; Eleuteri E; De Giuli L; Catalano O; Tondini C; Riccardi A
    Breast; 2011 Apr; 20(2):176-83. PubMed ID: 21146409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catching broken hearts: pre-clinical detection of doxorubicin and trastuzumab mediated cardiac dysfunction in the breast cancer setting.
    Saeed MF; Premecz S; Goyal V; Singal PK; Jassal DS
    Can J Physiol Pharmacol; 2014 Jul; 92(7):546-50. PubMed ID: 24959994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HER2+ breast cancer treatment and cardiotoxicity: monitoring and management.
    Jerusalem G; Lancellotti P; Kim SB
    Breast Cancer Res Treat; 2019 Sep; 177(2):237-250. PubMed ID: 31165940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardio-oncology, the myth of Sisyphus, and cardiovascular disease in breast cancer survivors.
    Mavrogeni SI; Sfendouraki E; Markousis-Mavrogenis G; Rigopoulos A; Noutsias M; Kolovou G; Angeli C; Tousoulis D
    Heart Fail Rev; 2019 Nov; 24(6):977-987. PubMed ID: 31134427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardio-oncology: the new frontier of clinical and preventive cardiology.
    Paris S; Tarantini L; Navazio A; Faggiano P
    Monaldi Arch Chest Dis; 2020 Jun; 90(2):. PubMed ID: 32571000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial to evaluate the impact of exercise-based cardiac rehabilitation for the prevention of chemotherapy-induced cardiotoxicity in patients with breast cancer: ONCORE study protocol.
    Díaz-Balboa E; González-Salvado V; Rodríguez-Romero B; Martínez-Monzonís A; Pedreira-Pérez M; Palacios-Ozores P; López-López R; Peña-Gil C; González-Juanatey JR
    BMC Cardiovasc Disord; 2021 Apr; 21(1):165. PubMed ID: 33827450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.